Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.5950 (1.55%) ($3.5950 - $3.5950) on Tue. Feb. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.48% (three month average) | RSI | 24 | Latest Price | $3.5950(1.55%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CGEN declines -6.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(87%) ARKG(82%) ARKK(82%) IWO(82%) BLOK(81%) | Factors Impacting CGEN price | CGEN will decline at least -2.24% in a week (0% probabilities). VIXM(-73%) VXX(-53%) UUP(-28%) UNG(-13%) EDOC(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.24% (StdDev 4.48%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.73(-426.29%) | Resistance Level | $3.81 | 5 Day Moving Average | $3.46(3.9%) | 10 Day Moving Average | $3.57(0.7%) | 20 Day Moving Average | $3.81(-5.64%) | To recent high | -49.8% | To recent low | 8.3% | Market Cap | $297m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |